Retinoids and skin: Microarrays shed new light on chemopreventive action of all-trans retinoic acid

Molecular Carcinogenesis

Volumn 46, Issue 8, 2007, Pages 634-639

  Cheepala, Satish B ^a   Syed, Zanobia ^a   Trutschl, Marjan ^b   Cvek, Urska ^b   Clifford, John L ^a,c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University   (United States)

^c NONE   (United States)

Author keywords

Microarray; Retinoid; Skin cancer

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; RAF PROTEIN; RETINOIC ACID; RETINOID;

CANCER MODEL; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; DNA MICROARRAY; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOPREVENTION; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN NEOPLASMS; TRETINOIN;

EID: 34547867087     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20346     Document Type: Conference Paper

References (46)

1. Chambon P. A decade of molecular biology of retinoic acid receptors. Faseb J 1996;10:940-954.
2. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841-850.
3. Yamakoshi Y, Fukasawa H, Yamauchi T, et al. Determination of endogenous levels of retinoic acid isomers in type II diabetes mellitus patients. Possible correlation with HbA1c values. Biol Pharm Bull 2002;25:1268-1271.
4. Kane MA, Chen N, Sparks S, Napoli JL. Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem J 2005;388:363-369.
5. Perissi V, Rosenfeld MG. Controlling nuclear receptors: The circular logic of cofactor cycles. Nat Rev Mol Cell Biol 2005;6:542-554.
6. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr Rev 1993;14:651-658.
7. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble vitamin A. J Exp Med 1925;47:753-777.
8. Chen L-C, De Luca LM. Retinoid effects on skin cancer. In: Mukhtar H, editor. Skin Cancer: Mechanisms and Human Relevance. Boca Raton: CRC Press; 1994. p 401-424.
9. Imakado S, Bickenbach JR, Bundman DS, et al. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 1995;9:317-329.
10. Attar PS, Wertz PW, McArthur M, Imakado S, Bickenbach JR, Roop DR. Inhibition of retinoid signaling in transgenic mice alters lipid processing and disrupts epidermal barrier function. Mol Endocrinol 1997;11:792-800.
11. Feng X, Peng ZH, Di W, et al. Suprabasal expression of a dominant-negative RXR alpha mutant in transgenic mouse epidermis impairs regulation of gene transcription and basal keratinocyte proliferation by RAR-selective retinoids. Genes Dev 1997;11:59-71.
12. Saitou M, Sugai S, Tanaka T, et al. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 1995;374:159-162.
13. Aneskievich BJ, Fuchs E. Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements. Mol Cell Biol 1992;12:4862-4871.
14. Calleja C, Messaddeq N, Chapellier B, et al. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev 2006;20:1525-1538.
15. Metzger D, Indra AK, Li M, et al. Targeted conditional somatic mutagenesis in the mouse: Temporally controlled knock out of retinoid receptors in epidermal keratinocytes. Methods Enzymol 2003;364:379-408.
16. Chapellier B, Mark M, Messaddeq N, et al. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. Embo J 2002;21:3402-3413.
17. Li M, Chiba H, Warot X, et al. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001;128:675-688.
18. Lotan R. Retinoids in cancer chemoprevention. Faseb J 1996a;10:1031-1039.
19. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992;54:63-128.
20. Zoumpourlis V, Solakidi S, Papathoma A, Papaevangeliou D. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis. Carcinogenesis 2003;24:1159-1165.
21. Verma AK. Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Res 1987;47:5097-5101.
22. Angel P, Szabowski A, Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 2001;20:2413-2423.
23. Greenhalgh DA, Welty DJ, Player A, Yuspa SH. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc Natl Acad Sci USA 1990;87:643-647.
24. Huang C, Ma WY, Dawson MI, Rincon M, Flavell RA, Dong Z. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 1997;94:5826-5830.
25. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res 1995;55:2774-2782.
26. Xu XC. Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Lett 2006 [EPUB ahead of print].
27. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001;1:181-193.
28. Berard J, Laboune F, Mukuna M, Masses, Kothary R, Bradley WE. Lung tumors in mice expressing an antisense RARbeta2 transgene. Faseb J 1996;10:1091-1097.
29. Chen CF, Goyette P, Lohnes D. RARgamma acts as a tumor suppressor in mouse keratinocytes. Oncogene 2004;23:5350-5359.
30. Indra AK, Castaneda E, Antal MC, et al. Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes. J Invest Dermatol 2007;127:1250-1260.
31. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
32. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996;93:10614-10619.
33. Sesto A, Navarro M, Burslem F, Jorcano JL. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002;99:2965-2970.
34. Bernard FX, Pedretti N, Rosdy M, Deguercy A. Comparison of gene expression profiles in human keratinocyte monolayer cultures, reconstituted epidermis and normal human skin; transcriptional effects of retinoid treatments in reconstituted human epidermis. Exp Dermatol 2002;11:59-74.
35. Steinmetz LM, Sinha H, Richards DR, et al. Dissecting the architecture of a quantitative trait locus in yeast. Nature 2002;416:326-330.
36. Porter JD, Khanna S, Kaminski HJ, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002;11:263-272.
37. Gazel A, Ramphal P, Rosdy M, et al. Transcriptional profiling of epidermal keratinocytes: Comparison of genes expressed in skin, cultured keratinocytes, and reconstituted epidermis, using large DNA microarrays. J Invest Dermatol 2003;121:1459-1468.
38. Dooley TP, Reddy SP, Wilborn TW, Davis RL. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun 2003;306:1026-1036.
39. Zhang W, Laborde PM, Coombes KR, Berry DA, Hamilton SR. Cancer genomics: Promises and complexities. Clin Cancer Res 2001;7:2159-2167.
40. Hummerich L, Muller R, Hess J, et al. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 2006;25:111-121.
41. Ridd K, Zhang SD, Edwards RE, et al. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Carcinogenesis 2006;27:1556-1566.
42. Haider AS, Peters SB, Kaporis H, et al. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006;126:869-881.
43. Nindl I, Dang C, Forschner T, et al. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer 2006;5:30.
44. Kathpalia VP, Mussak EN, Chow SS, et al. Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures. J Dermatol 2006;33:309-318.
45. Niles RM. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 2004;555:81-96.
46. Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 2000;114:444-455.